BOSTON SCIENTIFIC CORPORATION for BOSTON SCIENTIFIC CORPORATION

Trade (domestic/foreign) TRD

United States-Korea Free Trade Agreement, provisions specifically related to medical devices Columbia and Panama Free Trade Agreements

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); Pipeline & Hazardous Materials Safety Administration; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC)

Taxation/Internal Revenue Code TAX

S.17, the Medical Device Access and Innovation Protection Act- a bill to repeal the medical device tax S.262, A bill to repeal the excise tax on medical device manufacturers H.R. 436, the Protect Medical Innovation Act- a bill to repeal the medical device tax H.R. 734, To amend the Internal Revenue Code of 1986 to repeal the medical device tax; H.R. 488, Save Our Medical Devices Act of 2011- a bill to repeal the medical device tax H.R. 942, American Research and Competitiveness Act of 2011- a bill to extend the research credit through 2012 S. 239, the Innovate America Act, a bill to support innovation through tax credits such as research and development S. 1866, the Agree Act which calls for an increase in the rate of the alternative simplified research tax credit and makes such credit permanent Corporate tax reform- specifically the treatment of international earnings including the Chairman's International Tax Reform discussion draft

Contacted: Securities & Exchange Commission (SEC); Pipeline & Hazardous Materials Safety Administration; Food & Drug Administration (FDA); Transportation, Dept of (DOT); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 734 (112th), S. 262 (112th), H.R. 488 (112th), S. 239 (112th), H.R. 436 (112th), S. 17 (112th), H.R. 942 (112th), S. 1866 (112th)

Health Issues HCR

Medical Device User Fee Program Health care reform implementation and rulemaking proceedings including Accountable Care Organizations; Independent Payment Advisory Board; and comparative effectiveness research, National Coverage Decisions, Coverage with Evidence Determination Reform of the medical device regulatory system particularly for Class II devices through the 510(k) system including the following FDA related legislation: H.R. 3209 -Premarket Predictability Act H.R. 3203 -Novel Device Regulatory Relief Act H.R. 3230 -Keeping America Competitive through Harmonization Act H.R. 3205 -FDA Renewing Efficiency from Outside Review Management Act H.R. 3211 -Humanitarian Device Reform Act H.R. 3208 -Patients Come First Act H.R. 3206 -Cultivating Scientific Experts to Foster Innovation Act H.R. 3214 -Food and Drug Administration Mission Reform Act H.R. 3207 -Modernizing Laboratory Test Standards for Patients Act H.R. 3204 -Guidance Accountability and Transparency Act S. 1700 -The Medical Device Regulatory Improvement Act S. 1865 -The Patient Access to Medical Innovation Act S. 1943 -Novel Device Regulatory Relief Act of 2011 S. 1972 -A bill to amend the Food and Drug Administration's mission S. 1995 -A bill to enhance Food and Drug Administration oversight of medical device recalls, to provide for the conditional clearance of certain medical devices, and for other purposes.

Contacted: Centers For Medicare and Medicaid Services (CMS); Transportation, Dept of (DOT); SENATE; Securities & Exchange Commission (SEC); Pipeline & Hazardous Materials Safety Administration; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 1943 (112th), H.R. 3207 (112th), H.R. 3204 (112th), H.R. 3211 (112th), H.R. 3214 (112th), H.R. 3209 (112th), H.R. 3230 (112th), S. 1700 (112th), S. 1865 (112th), H.R. 3208 (112th), H.R. 3206 (112th), H.R. 3205 (112th), H.R. 3203 (112th), S. 1995 (112th), S. 1972 (112th)

Medicare/Medicaid MMM

S.454, Strengthening Program Integrity and Accountability in Health Care Act of 2011, a bill to prevent fraud, waste, and abuse under Medicare, Medicaid, and CHIP, and for other purposes H.R. 675, Strengthening Medicare Anti-Fraud Measures Act of 2011, to expand the permissive exclusion from participation in Federal health care programs to individuals and entities affiliated with sanctioned entities

Contacted: Securities & Exchange Commission (SEC); SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Pipeline & Hazardous Materials Safety Administration; Transportation, Dept of (DOT); Food & Drug Administration (FDA)

Bills named: S. 454 (112th), H.R. 675 (112th)

Budget/Appropriations BUD

Appropriations for the Food and Drug Administration, particularly the Center for Devices and Radiological Health Appropriations for pain management awareness programs

Contacted: Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Pipeline & Hazardous Materials Safety Administration; Transportation, Dept of (DOT); Securities & Exchange Commission (SEC)

Transportation TRA

H.R. 658, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries S.223, the FAA Reauthorization and Reform Act of 2011, provisions related to the transportation of lithium batteries

Contacted: Pipeline & Hazardous Materials Safety Administration; Securities & Exchange Commission (SEC); Transportation, Dept of (DOT); SENATE; Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Bills named: S. 223 (112th), H.R. 658 (112th)

Education EDU

S.758, A bill to establish a Science, Technology, Engineering, and Math (STEM) Master Teacher Corps program S.716, Innovation Inspiration School Grant Program Act- to promote STEM education

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); Pipeline & Hazardous Materials Safety Administration; Transportation, Dept of (DOT); SENATE

Bills named: S. 716 (112th), S. 758 (112th)

Manufacturing MAN

Proposed rules regarding disclosure related to conflict minerals

Contacted: SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Transportation, Dept of (DOT); Securities & Exchange Commission (SEC); Pipeline & Hazardous Materials Safety Administration; HOUSE OF REPRESENTATIVES